CEO Mike Gorenstein from Cronos Group (NASDAQ: CRON) tells Proactive Investors it's been a long process to get listed on Nasdaq but they've finally achieved their goal.
The company is dual listed in Canada and has production facilities there, but Gorenstein says Cronos wants to expand production into the U.S. once marijuana becomes legal at the federal level.
Price: 10.79 USD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Health
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) CEO Daniel Cohen tells Proactive it has filed an application with the FDA to receive an orphan drug designation for the use of DMT in preventing kidney injuries in patients undergoing kidney transplants. Cohen says the group aims to unlock the potential...
Retail & consumer
Retail & consumer
Industry & services
Prev article
